510(k) Report

510(k) · Cleared

Cleared

Contrast Delivery System - Dual Shot Alpha

K062168510(k) TraditionalCleared Aug 18, 200618-day reviewClass II21 CFR 870.1650

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Nemoto Kyorindo Co., Ltd. · DXT Injector And Syringe, Angiographic

Cleared on Aug 18, 2006 as substantially equivalent to K052633 (Nemoto Kyorindo Co., Ltd., 2005) after an 18-day review. Its family tree reaches back 5 generations to 1995. 2 later devices descend from it.

Decided
Aug 18, 2006
Review
18 days
Class
Class II
Product code
DXT
Recalls
None
Predicates
1

Its longest line of descent runs back 5 generations to K934086 (1995). 2 later devices descend from it, 1 citing it directly.

  1. Root · 5 generations backK934086 Medrad Envision CT Injector and Qwik Fit SyringeMedrad, Inc. · 1995
  2. 4 generations backK993728 Medrad Envision CT Injector SystemMedrad, Inc. · 1999
  3. 3 generations backK023183 Medrad Stellant CT Injector SystemMedrad, Inc. · 2003 · Recalled
  4. 2 generations backK033881 Medrad Stellant CT Injector System with Imaging System Interface…Medrad, Inc. · 2004 · Recalled
  5. 1 generation backK052633 Dual Shot - Contrast Delivery SystemNemoto Kyorindo Co., Ltd. · 2005
  6. This deviceK062168 Contrast Delivery System - Dual Shot AlphaNemoto Kyorindo Co., Ltd. · 2006
  7. Descendant · cites it directly · 1 of its ownK133189 Dual Shot Alpha 7Nemoto Kyorindo Co., Ltd. · 2014
  8. Descendant · 2 generations on · 0 of its ownK173450 PRESS DUO elite, PRESS DUO elite AGNemoto Kyorindo Co., Ltd. · 2018

Most influential descendants

Showing 2 of 2 · See all
  • K133189Dual Shot Alpha 7Nemoto Kyorindo Co., Ltd. · 2014 · cites it directly1descendant
  • K173450PRESS DUO elite, PRESS DUO elite AGNemoto Kyorindo Co., Ltd. · 2018 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−5K934086Medrad Envision CT Injector and Qwik Fit SyringeMedrad, Inc.1995—
−4K993728Medrad Envision CT Injector SystemMedrad, Inc.1999—
−3K023183Medrad Stellant CT Injector SystemMedrad, Inc.20036
−2K033881Medrad Stellant CT Injector System with Imaging System Interface ModuleMedrad, Inc.20041
−1K052633Dual Shot - Contrast Delivery SystemNemoto Kyorindo Co., Ltd.2005—
0 (this device)K062168Contrast Delivery System - Dual Shot AlphaNemoto Kyorindo Co., Ltd.2006—
+1K133189Dual Shot Alpha 7Nemoto Kyorindo Co., Ltd.2014—
+2K173450PRESS DUO elite, PRESS DUO elite AGNemoto Kyorindo Co., Ltd.2018—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201410
201810
FIG. 1 — Lineage of K062168, 1995–2018Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DXT? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DXT device

  1. #1 K253048 High Pressure Syringe; Pressure Connecting…score 13.6 · 9 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K052633Dual Shot - Contrast Delivery System
Our reading of the summary gave K056233, which is not a number in FDA’s lists. Corrected to the number with two digits swapped whose FDA name carries the summary’s words for the device, “DUAL SHOT - CONTRAST DELIVERY SYSTEM”.
Nemoto Kyorindo Co., Ltd.2005—

What descends from it? (2)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K133189Dual Shot Alpha 7Nemoto Kyorindo Co., Ltd.20141

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 11 years and passes through 2 companies; a new generation was cleared every 1.6 years on median.
  • 2 of the 5 ancestors have a recall of any class.
  • Of its descendants, K133189 (Nemoto Kyorindo Co., Ltd., 2014) has gone furthest, with 1 descendant of its own.

How does its category compare?

All DXT devices

DXT Injector And Syringe, Angiographic: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · DXT

1in 2025

2007: 32008: 22009: 62010: 12011: 42013: 22014: 62015: 72016: 82017: 72018: 92019: 42020: 32021: 12023: 12024: 42025: 12026 (partial year): 7
2007high 9 (2018) · low 0 (2012)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DXT

138in 2024

2007: 182 days median2009: 137 days median2011: 69 days median2014: 144 days median2015: 153 days median2016: 172 days median2017: 183 days median2018: 93 days median2019: 96 days median2020: 154 days median2024: 138 days median2026 (partial year): 264 days median
2007high 264 (2026) · low 69 (2011)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · DXT

10in 2024

2007: 42008: 32009: 72010: 32011: 32012: 72015: 12018: 22020: 12021: 12023: 22024: 102026 (partial year): 6
2007high 10 (2024) · low 0 (2013)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · DXT

97in 2025

2007: 1072008: 1682009: 1882010: 1242011: 1332012: 1352013: 1412014: 972015: 1352016: 1522017: 1282018: 1292019: 1212020: 932021: 1322022: 1112023: 1172024: 1182025: 97
2007high 188 (2009) · low 93 (2020)2025

MAUDE reports naming product code DXT, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200731824107
20082—3168
200961377188
20101—3124
20114693133
20120—7135
20132—0141
20146144097
201571531135
201681720152
201771830128
20189932129
20194960121
20203154193
20211—1132
20220—0111
20231—2117
2024413810118
20251—097
202672646—

What is it indicated for?

The Contrast Delivery System - Dual Shot Alpha is an intravascular injection system intended for the administration of ionic and non-ionic contrast media and saline used in conjunction with computed X-Ray tomography (CT).

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K062168: Contrast Delivery System - Dual Shot Alpha.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K062168

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026